QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

Lorenzo Guglielmetti; Simon Tiberi; Matthew Burman; Heinke Kunst; Christian Wejse; Tamar Togonidze; Graham Bothamley; Christoph Lange; TBNET QTc survey collaboration; Hasan Hafizi; Ohanna Kirakosyan; Rudolf Rumetshofer; Åse Bengård Andersen; Pernille Ravn; Shailesh Kolekar; Andrii Dudnyk; Moerida Belton; Martin Dedicoat

doi:10.1183/13993003.00537-2018

QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study

Lorenzo Guglielmetti, Simon Tiberi, Matthew Burman, Heinke Kunst, Christian Wejse, Tamar Togonidze, Graham Bothamley, Christoph Lange, TBNET QTc survey collaboration, Hasan Hafizi, Ohanna Kirakosyan, Rudolf Rumetshofer, Åse Bengård Andersen, Pernille Ravn, Shailesh Kolekar, Andrii Dudnyk, Moerida Belton, Martin Dedicoat

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

48 Citationer (Scopus)

Originalsprog	Engelsk
Artikelnummer	1800537
Tidsskrift	The European Respiratory Journal
Vol/bind	52
Udgave nummer	2
Antal sider	4
ISSN	0903-1936
DOI	https://doi.org/10.1183/13993003.00537-2018
Status	Udgivet - 2018

Adgang til dokumentet

10.1183/13993003.00537-2018

Citationsformater

Guglielmetti, L., Tiberi, S., Burman, M., Kunst, H., Wejse, C., Togonidze, T., Bothamley, G., Lange, C., TBNET QTc survey collaboration, Hafizi, H., Kirakosyan, O., Rumetshofer, R., Andersen, Å. B., Ravn, P., Kolekar, S., Dudnyk, A., Belton, M., & Dedicoat, M. (2018). QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. The European Respiratory Journal, 52(2), Artikel 1800537. https://doi.org/10.1183/13993003.00537-2018

Guglielmetti, L, Tiberi, S, Burman, M, Kunst, H, Wejse, C, Togonidze, T, Bothamley, G, Lange, C, TBNET QTc survey collaboration, Hafizi, H, Kirakosyan, O, Rumetshofer, R, Andersen, ÅB, Ravn, P, Kolekar, S, Dudnyk, A, Belton, M & Dedicoat, M 2018, 'QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study', The European Respiratory Journal, bind 52, nr. 2, 1800537. https://doi.org/10.1183/13993003.00537-2018

@article{bd0ce405998846e9b58a5543dfca856e,

title = "QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study",

author = "Lorenzo Guglielmetti and Simon Tiberi and Matthew Burman and Heinke Kunst and Christian Wejse and Tamar Togonidze and Graham Bothamley and Christoph Lange and {TBNET QTc survey collaboration} and Hasan Hafizi and Ohanna Kirakosyan and Rudolf Rumetshofer and Andersen, {{\AA}se Beng{\aa}rd} and Pernille Ravn and Shailesh Kolekar and Andrii Dudnyk and Moerida Belton and Martin Dedicoat",

year = "2018",

doi = "10.1183/13993003.00537-2018",

language = "English",

volume = "52",

journal = "The European Respiratory Journal",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "2",

}

TY - JOUR

T1 - QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe

T2 - a Tuberculosis Network European Trialsgroup (TBnet) study

AU - Guglielmetti, Lorenzo

AU - Tiberi, Simon

AU - Burman, Matthew

AU - Kunst, Heinke

AU - Wejse, Christian

AU - Togonidze, Tamar

AU - Bothamley, Graham

AU - Lange, Christoph

AU - TBNET QTc survey collaboration

AU - Hafizi, Hasan

AU - Kirakosyan, Ohanna

AU - Rumetshofer, Rudolf

AU - Andersen, Åse Bengård

AU - Ravn, Pernille

AU - Kolekar, Shailesh

AU - Dudnyk, Andrii

AU - Belton, Moerida

AU - Dedicoat, Martin

PY - 2018

Y1 - 2018

U2 - 10.1183/13993003.00537-2018

DO - 10.1183/13993003.00537-2018

M3 - Journal article

C2 - 29880656

SN - 0903-1936

VL - 52

JO - The European Respiratory Journal

JF - The European Respiratory Journal

IS - 2

M1 - 1800537

ER -